Literature DB >> 28235949

BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells.

Pengcheng Cai1,2, Laszlo Kovacs1, Sam Dong1, Guangyu Wu1, Yunchao Su3,4,5,6.   

Abstract

In the present study, we investigated the effect of bone morphogenetic protein 4 (BMP4) on PDGF-induced cell proliferation and collagen synthesis in pulmonary artery smooth muscle cells (PASMCs). Normal human PASMCs were incubated with and without PDGF-BB in the absence and presence of BMP4 for 0.5 to 24 h. The protein levels of collagen-I, p-Smad2/3, p-Smad1/5, and intracellular active TGF-β1, calpain activity, and cell proliferation were then measured. The results showed that BMP4 induced an increase in p-Smad1/5 but had no effect on the protein levels of collagen-I, p-Smad2/3, and intracellular active TGF-β1 and calpain activity in control PASMCs. Nevertheless, BMP4 attenuated increases in cell proliferation and protein levels of collagen-I, p-Smad2/3, and intracellular active TGF-β1 and calpain activity in PASMCs exposed to PDGF-BB. Moreover, BMP4 increased PKA activity and inhibition of PKA prevented the inhibitory effects of BMP4 on PDGF-BB-induced calpain activation in normal PASMCs. The PKA activator forskolin recapitulated the suppressive effect of BMP4 on PDGF-induced calpain activation. Furthermore, BMP4 prevented a PDGF-induced decrease in calpain-2 phosphorylation at serine-369 in normal PASMCs. Finally, BMP4 did not attenuate PDGF-induced increases in cell proliferation, collagen-I protein levels, and calpain activation and did not induce PKA activation and did not prevent a PDGF-induced decrease in calpain-2 phosphorylation at serine-369 in PASMCs from idiopathic pulmonary arterial hypertension (PAH) patients. These data demonstrate that BMP4 inhibits PDGF-induced cell proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in normal PASMCs. The inhibitory effects of BMP4 on PDGF-induced cell proliferation, collagen synthesis, and calpain-2 activation are impaired in PASMCs from PAH patients, which may contribute to pulmonary vascular remodeling in PAH.

Entities:  

Keywords:  lung; pulmonary hypertension; vascular smooth muscle cells

Mesh:

Substances:

Year:  2017        PMID: 28235949      PMCID: PMC5451598          DOI: 10.1152/ajplung.00260.2016

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  35 in total

1.  Impaired transforming growth factor-beta signaling in idiopathic pulmonary arterial hypertension.

Authors:  Amy Richter; Michael E Yeager; Ari Zaiman; Carlyne D Cool; Norbert F Voelkel; Rubin M Tuder
Journal:  Am J Respir Crit Care Med       Date:  2004-09-10       Impact factor: 21.405

2.  Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

Authors:  K B Lane; R D Machado; M W Pauciulo; J R Thomson; J A Phillips; J E Loyd; W C Nichols; R C Trembath
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

3.  Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

Authors:  Rajiv D Machado; Micheala A Aldred; Victoria James; Rachel E Harrison; Bhakti Patel; Edward C Schwalbe; Ekkehard Gruenig; Bart Janssen; Rolf Koehler; Werner Seeger; Oliver Eickelberg; Horst Olschewski; C Gregory Elliott; Eric Glissmeyer; John Carlquist; Miryoung Kim; Adam Torbicki; Anna Fijalkowska; Grzegorz Szewczyk; Jasmine Parma; Marc J Abramowicz; Nazzareno Galie; Hiroko Morisaki; Shingo Kyotani; Norifumi Nakanishi; Takayuki Morisaki; Marc Humbert; Gerald Simonneau; Olivier Sitbon; Florent Soubrier; Florence Coulet; Nicholas W Morrell; Richard C Trembath
Journal:  Hum Mutat       Date:  2006-02       Impact factor: 4.878

4.  Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.

Authors:  Carl Atkinson; Susan Stewart; Paul D Upton; Rajiv Machado; Jennifer R Thomson; Richard C Trembath; Nicholas W Morrell
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

5.  Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension.

Authors:  David B Frank; Amir Abtahi; D J Yamaguchi; Suzanne Manning; Yu Shyr; Ambra Pozzi; H Scott Baldwin; Joyce E Johnson; Mark P de Caestecker
Journal:  Circ Res       Date:  2005-08-11       Impact factor: 17.367

6.  BMP4 increases canonical transient receptor potential protein expression by activating p38 MAPK and ERK1/2 signaling pathways in pulmonary arterial smooth muscle cells.

Authors:  Xiaoyan Li; Wenju Lu; Xin Fu; Yi Zhang; Kai Yang; Nanshan Zhong; Pixin Ran; Jian Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

7.  Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation.

Authors:  A Glading; R J Bodnar; I J Reynolds; H Shiraha; L Satish; D A Potter; H C Blair; A Wells
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

8.  Activation of Src kinase in platelet-derived growth factor-B-dependent tubular regeneration after acute ischemic renal injury.

Authors:  Mikiko Takikita-Suzuki; Masakazu Haneda; Masakiyo Sasahara; M Koji Owada; Takahiko Nakagawa; Motohide Isono; Shoichi Takikita; Daisuke Koya; Kazumasa Ogasawara; Ryuichi Kikkawa
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 9.  Inflammation, growth factors, and pulmonary vascular remodeling.

Authors:  Paul M Hassoun; Luc Mouthon; Joan A Barberà; Saadia Eddahibi; Sonia C Flores; Friedrich Grimminger; Peter Lloyd Jones; Michael L Maitland; Evangelos D Michelakis; Nicholas W Morrell; John H Newman; Marlene Rabinovitch; Ralph Schermuly; Kurt R Stenmark; Norbert F Voelkel; Jason X-J Yuan; Marc Humbert
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

10.  Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.

Authors:  Rachel E Nisbet; Jennifer M Bland; Dean J Kleinhenz; Patrick O Mitchell; Erik R Walp; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-11       Impact factor: 6.914

View more
  8 in total

1.  PFKFB3 in Smooth Muscle Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.

Authors:  Laszlo Kovacs; Yapeng Cao; Weihong Han; Louise Meadows; Anita Kovacs-Kasa; Dmitry Kondrikov; Alexander D Verin; Scott A Barman; Zheng Dong; Yuqing Huo; Yunchao Su
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

2.  Chordin-like 2 influences the differentiation fate of retinal pigment epithelium cells by dynamically regulating BMP pathway.

Authors:  Duo Li; Song-Tao Yuan; Xin-Yi Xie; Han Shen; Qing-Huai Liu; Yong Yao
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

3.  let-7b-5p suppresses the proliferation and migration of pulmonary artery smooth muscle cells via down-regulating IGF1.

Authors:  Yadi Zhang; Sihui Tang; Wanchun Yang; Fangbing Du
Journal:  Clinics (Sao Paulo)       Date:  2022-05-27       Impact factor: 2.898

4.  Bone morphogenetic protein 4 regulates immortalized chicken preadipocyte proliferation by promoting G1/S cell cycle progression.

Authors:  Hongyan Chen; Chang Liu; Chong Chen; Zhiyong Su; Jingting Shu; Ming Zhang; Hui Li; Bohan Cheng
Journal:  FEBS Open Bio       Date:  2019-04-30       Impact factor: 2.693

5.  Potential Role of Circulating Endoglin in Hypertension via the Upregulated Expression of BMP4.

Authors:  Eunate Gallardo-Vara; Luis Gamella-Pozuelo; Lucía Perez-Roque; José L Bartha; Irene Garcia-Palmero; J Ignacio Casal; José M López-Novoa; Miguel Pericacho; Carmelo Bernabeu
Journal:  Cells       Date:  2020-04-16       Impact factor: 6.600

6.  Protective effect of baicalin against pulmonary arterial hypertension vascular remodeling through regulation of TNF-α signaling pathway.

Authors:  Xia Xue; Shanshan Zhang; Wen Jiang; Jue Wang; Qian Xin; Chao Sun; Kailin Li; Tonggang Qi; Yun Luan
Journal:  Pharmacol Res Perspect       Date:  2021-02

7.  HDAC6 Activates ERK in Airway and Pulmonary Vascular Remodeling of Chronic Obstructive Pulmonary Disease.

Authors:  Yunchao Su; Weihong Han; Anita Kovacs-Kasa; Alexander D Verin; Laszlo Kovacs
Journal:  Am J Respir Cell Mol Biol       Date:  2021-12       Impact factor: 6.914

8.  PINK1-induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension.

Authors:  Asish Dasgupta; Kuang-Hueih Chen; Patricia D A Lima; Jeffrey Mewburn; Danchen Wu; Ruaa Al-Qazazi; Oliver Jones; Lian Tian; Francois Potus; Sebastien Bonnet; Stephen L Archer
Journal:  FASEB J       Date:  2021-08       Impact factor: 5.834

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.